Publications in collaboration with researchers from Universidad Central de Chile (12)

2023

  1. In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies

    Journal of Biomolecular Structure and Dynamics, Vol. 41, Núm. 22, pp. 13250-13259

2022

  1. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

2019

  1. Aporphines and Alzheimer's Disease: Towards a Medical Approach Facing the Future

    Current medicinal chemistry, Vol. 26, Núm. 18, pp. 3253-3259

  2. Hesperidin as a neuroprotective agent: A review of animal and clinical evidence

    Molecules, Vol. 24, Núm. 3

  3. In silico prediction of P-glycoprotein binding: Insights from molecular docking studies

    Current Medicinal Chemistry, Vol. 26, Núm. 10, pp. 1746-1760

  4. Potent in Vitro α-Glucosidase Inhibition of Secondary Metabolites Derived from Dryopteris cycadina

    Molecules, Vol. 24, Núm. 3

  5. Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders

    Molecules, Vol. 24, Núm. 3

2018

  1. Ligand and structure-based modeling of passive diffusion through the blood-brain barrier

    Current Medicinal Chemistry, Vol. 25, Núm. 9, pp. 1073-1089

  2. Nanomedicine and Parkinson’s disease: A nanoparticle medical approach

    Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Nova Science Publishers, Inc.), pp. 153-168

2017

  1. A medical approach to the monoamine oxidase inhibition by using 7H-benzo[e]perimidin-7-one derivatives

    Current Topics in Medicinal Chemistry, Vol. 17, Núm. 7

  2. Aporphine alkaloids and their antioxidant medical application: From antineoplastic agents to motor dysfunction diseases

    Current Organic Chemistry, Vol. 21, Núm. 4, pp. 342-347

  3. Molecular docking and drug discovery in β-adrenergic receptors

    Current Medicinal Chemistry, Vol. 24, Núm. 39, pp. 4340-4359